JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 30, 2006; DOI: 10.1124/jpet.106.108902


0022-3565/06/3193-1386-1394$20.00
JPET 319:1386-1394, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108902v1
319/3/1386    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabiyi, A. C.
Right arrow Articles by Brading, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabiyi, A. C.
Right arrow Articles by Brading, A. F.

NEUROPHARMACOLOGY

The Use of the Isolated Mouse Whole Bladder for Investigating Bladder Overactivity

Adebola C. Fabiyi, and Alison F. Brading

The Oxford Continence Group, Department of Pharmacology, University of Oxford, Oxford, United Kingdom

The isolated mouse whole bladder was used to study in vitro bladder overactivity evoked by intramural nerve sensitization with bradykinin, mimicking neurogenic bladder overactivity secondary to bladder inflammation. Intravesical pressure responses to intramural electrical stimulation of intramural nerves were measured under isovolumetric condition. Validation showed that carbachol produced a dose-response curve closely mirroring that observed in the isolated muscle strips and demonstrated the dual nature of electrically evoked neurotransmission, consisting of a cholinergic component largely mediated by M3 receptors and a purinergic component mediated by P2X receptors. ATP generated a biphasic dose-response curve, suggesting that the P2X receptors may be heterogeneous in distribution. Characterization of bradykinin receptors showed bradykinin to be extremely potent in exciting the bladder, producing a dose-response curve with an EC50 of 90 nM, and bradykinin also enhanced electrically evoked bladder contractions. These effects were inhibited by the B2 receptor antagonist HOE 140 (D-Arg0-Arg1-Pro2-Hyp3-Gly4-Thi5-Ser6-D-Tic7-Oic8-Arg9) but not the B1 receptor antagonist desArg10 HOE 140 (H-D-Arf-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-OH) and were also modulated by {alpha},beta,methyleneATP. The isolated mouse whole bladder has proved a viable, robust model in which to demonstrate the pharmacological characteristic of the bladder and adds to the repertoire of in vitro tools for investigating potential therapeutic agents.


Received June 2, 2006; accepted August 28, 2006.

Address correspondence to: Adebola C. Fabiyi, Oxford Continence Group, University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK. E-mail: adebola.fabiyi{at}nds.ox.ac.uk




This article has been cited by other articles:


Home page
FASEB J.Home page
A. C Fabiyi and A. F Brading
Neuromodulatory Effect of delta 9-THC on an In Vitro Model of Overactive Bladder Secondary to Bradykinin Sensitization of Intramural Nerves
FASEB J, March 1, 2007; 21(6): LB85 - LB85.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.